Study Experimentally Validates Compugen's Computationally Predicted Drug Target for Multiple Myeloma

The company said that the protein's expression profile indicates that it might also be useful as a diagnostic and prognostic marker for multiple myeloma.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.